Skip to content

Does AI-assisted Colonoscopy Improve Adenoma Detection in Screening Colonoscopy?

Does AI-assisted Colonoscopy Improve Adenoma Detection in Screening Colonoscopy? A Multi-center Randomized Controlled

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04422548
Enrollment
2994
Registered
2020-06-09
Start date
2019-11-28
Completion date
2020-11-27
Last updated
2020-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Screening Colonoscopy

Brief summary

To date, there is a lack of large-scale randomized controlled study using AI assistance in the detection of polyps/adenoma in a screening population. The correlation of fecal occult blood test (FIT or FOBT) and the advantage of AI-assisted colonoscopy has not been investigated. There is also a lack of information of the benefit of AI-assisted colonoscopy in experienced colonoscopist versus trainee/resident.

Detailed description

There are several studies showing that AI-assisted colonoscopy can help in identifying and characterizing polyps found on colonoscopy. * Byrne et al demonstrated that their AI model for real-time assessment of endoscopic video images of colorectal polyp can differentiate between hyperplastic diminutive polyps vs adenomatous polyps with sensitivity of 98% and specificity of 83% (Byrne et al. GUT 2019) * Urban et al designed and trained deep CNNs to detect polyps in archived video with a ROC curve of 0.991 and accuracy of 96.4%. The total number of polyps identified is significantly higher but mainly in the small (1-3mm and 4-6mm polyps) (Urban et al. Gastroenterol 2018) * Wang et al conducted an open, non-blinded trial consecutive patients (n=1058) prospectively randomized to undergo diagnostic colonoscopy with or without AI assistance. They found that AI system increased ADR from 20.3% to 29.1% and the mean number of adenomas per patients from 0.31 to 0.53. This was due to a higher number of diminutive polyps found while there was no statistic difference in larger adenoma. (Wang et al. GUT 2019). In this study, they excluded patients with IBD, CRC and colorectal surgery. The patients presented with symptoms to hospital for investigation. To date, there is a lack of large-scale randomized controlled study using AI assistance in the detection of polyps/adenoma in a screening population. The correlation of fecal occult blood test (FIT or FOBT) and the advantage of AI-assisted colonoscopy has not been investigated. There is also a lack of information of the benefit of AI-assisted colonoscopy in experienced colonoscopist versus trainee/resident.

Interventions

This is a multi-center prospective randomized controlled study comparing real-time AI-assisted colonoscopy versus standard colonoscopy in a real-life setting.

PROCEDUREStandard Colonoscopy

Standard Colonoscopy

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients receiving colonoscopy screening * Patients aged 45-75 years * Both patients who have or have not done a FIT test and both FIT +ve and FIT -ve subjects

Exclusion criteria

* Patients who have symptom(s) suggestive of colorectal diseases * Patients who have a history of inflammatory bowel disease, colorectal cancer or polyposis syndrome (anaemia, bloody stool, tenesmus and obstructive symptoms) * Patients who had colonoscopy or other investigation of colon and rectum in the past 10 years * Patients who had surgery for colorectal diseases * Patients who cannot tolerate bowel preparation or have suboptimal bowel preparations (Boston Bowel Preparation Scale) * Cannot reach caecum * Patients who are incompetent in giving informed consent

Design outcomes

Primary

MeasureTime frameDescription
Per-patient ADR in each group12 monthsFor the AI-Assisted group, it is defined as the number of patients with at least 1 adenoma identified in the colon divided by the total number of patients in the AI-Assisted group.

Countries

Hong Kong

Contacts

Primary ContactAndrew Ming Yeung HO
andrewho@cuhk.edu.hk26371398
Backup ContactThomas Yuen Tung LAM
thomaslam@cuhk.edu.hk26370355

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026